Altamira Therapeutics Ltd. — Net Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ae3aae27-fe20-4175-94a8-4a7bd88ed0bb/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | — | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-018959 |
| FY 2019 | — | 2019-01-01 – 2019-12-31 | evidence 0001213900-21-018959 |
| FY 2018 | — | 2018-01-01 – 2018-12-31 | evidence 0001213900-21-018959 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).